Cite

HARVARD Citation

    Rothenberg, M. et al. (2019). Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL‐22Fc): A Potential Therapy for Epithelial Injury. Clinical pharmacology & therapeutics. 105 (1), pp. 177-189. [Online]. 
  
Back to record